ðˈʌs, blˈɑːkɪŋ ðə bˈaɪndɪŋ ʌv ˌɛndʒˌiːˈɛf ɐlˈaʊz fɚðɪ ɐlˌiːvɪˈeɪʃən ʌv sˈaɪd ɪfˈɛkts fɹʌm ɪnhˈɛɹɪɾᵻd ɑːɹθɹˈaɪɾɪs, pətˈɛnʃəli hˈaɪlaɪɾɪŋ ɐ mˈɑːdəl tʊ ˈeɪd hjˈuːmən ɪnflˈæmətˌoːɹi ɑːɹθɹˈaɪɾɪs.
Thus, blocking the binding of NGF allows for the alleviation of side effects from inherited arthritis, potentially highlighting a model to aid human inflammatory arthritis.